Does TOFACITINIB Cause Coronary artery occlusion? 62 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Coronary artery occlusion have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.0% of all adverse event reports for TOFACITINIB.
62
Reports of Coronary artery occlusion with TOFACITINIB
0.0%
of all TOFACITINIB reports
1
Deaths
36
Hospitalizations
How Dangerous Is Coronary artery occlusion From TOFACITINIB?
Of the 62 reports, 1 (1.6%) resulted in death, 36 (58.1%) required hospitalization, and 6 (9.7%) were considered life-threatening.
Is Coronary artery occlusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Coronary artery occlusion?
ADALIMUMAB (1,392)
TICAGRELOR (370)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (296)
ROSUVASTATIN (283)
METOPROLOL (230)
SACUBITRIL\VALSARTAN (204)
ASPIRIN (190)
RISANKIZUMAB-RZAA (181)
EVOLOCUMAB (162)
CLOPIDOGREL BISULFATE (155)
Which TOFACITINIB Alternatives Have Lower Coronary artery occlusion Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN